| SMS Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532815 |
NSE Symbol : SMSPHARMA |
P/E(TTM) : 41.28 |
|
ISIN Demat : INE812G01025 |
Div & Yield% : 0.10 |
EPS(TTM) : 9.32 |
|
Book Value(₹) : 81.18 |
Market Cap(₹Cr) : 3,602.79 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 210.45 | 242.43 | 196.05 | 248.20 | 173.35 | 196.75 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 210.45 | 242.43 | 196.05 | 248.20 | 173.35 | 196.75 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.75 | 1.43 | 0.59 | 1.42 | 2.13 | 1.30 |
| Total Income | 214.20 | 243.86 | 196.64 | 249.62 | 175.48 | 198.05 |
| Total Expenditure | 166.65 | 194.05 | 157.19 | 206.85 | 140.05 | 164.89 |
| PBIDT | 47.55 | 49.81 | 39.45 | 42.77 | 35.43 | 33.17 |
| Interest | 6.22 | 5.74 | 5.84 | 5.07 | 4.20 | 4.61 |
| PBDT | 41.32 | 44.08 | 33.61 | 37.70 | 31.23 | 28.56 |
| Depreciation | 10.02 | 10.02 | 9.75 | 8.64 | 8.70 | 8.62 |
| Tax | 7.25 | 8.25 | 5.00 | 4.65 | 4.99 | 4.70 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.72 | 0.66 | 0.65 | 3.79 | 0.37 | 0.98 |
| Reported Profit After Tax | 23.34 | 25.14 | 18.21 | 20.62 | 17.17 | 14.26 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 23.34 | 25.14 | 18.21 | 20.62 | 17.17 | 14.26 |
| EPS (Unit Curr.) | 2.57 | 2.82 | 2.05 | 2.43 | 2.03 | 1.68 |
| EPS (Adj) (Unit Curr.) | 2.57 | 2.82 | 2.05 | 2.43 | 2.03 | 1.68 |
| Calculated EPS (Unit Curr.) | 2.49 | 2.68 | 2.05 | 2.33 | 2.03 | 1.68 |
| Calculated EPS (Adj) (Unit Curr.) | 2.49 | 2.68 | 2.05 | 2.33 | 2.03 | 1.68 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.97 | 10.74 | 8.22 | 9.30 | 8.11 | 6.74 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.97 | 10.74 | 8.22 | 9.30 | 8.11 | 6.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.37 | 9.37 | 8.87 | 8.87 | 8.47 | 8.47 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.59 | 20.55 | 20.12 | 17.23 | 20.44 | 16.86 |
| PBDTM(%) | 19.63 | 18.18 | 17.14 | 15.19 | 18.02 | 14.52 |
| PATM(%) | 11.09 | 10.37 | 9.29 | 8.31 | 9.90 | 7.25 |
